In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ferriprox Drug Master File in Korea (Ferriprox KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ferriprox. The MFDS reviews the Ferriprox KDMF as part of the drug registration process and uses the information provided in the Ferriprox KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ferriprox KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ferriprox API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ferriprox suppliers with KDMF on PharmaCompass.